Literature DB >> 18076905

Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder.

Michael J Zvolensky1, Peter Lewinsohn, Amit Bernstein, Norman B Schmidt, Julia D Buckner, John Seeley, Marcel O Bonn-Miller.   

Abstract

The present study prospectively evaluated cannabis use, abuse, and dependence in relation to the development of panic attacks and panic disorder. Participants at the start of the study were adolescents (n=1709) with a mean age of 16.6 years (SD=1.2; time 1) and were re-assessed 1 year later (time 2) and then again as young adults (time 3; mean age=24.2 years, SD=0.6). Results indicated that cannabis use and dependence were significantly prospectively associated with an increased odds for the development of panic attacks and panic disorder. However, cannabis was not incrementally associated with the development of panic after controlling for daily cigarette smoking. The theoretical and clinical implications of these findings are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18076905      PMCID: PMC2600535          DOI: 10.1016/j.jpsychires.2007.10.012

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  35 in total

1.  Alcohol and drug use in second-year medical students at the University of Leeds.

Authors:  M Pickard; L Bates; M Dorian; H Greig; D Saint
Journal:  Med Educ       Date:  2000-02       Impact factor: 6.251

2.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

3.  Motivational factors associated with the use of cannabis (marihuana).

Authors:  E N Gale; G Guenther
Journal:  Br J Addict Alcohol Other Drugs       Date:  1971-11

4.  Adverse effects of marijuana: selected issues.

Authors:  S Cohen
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

Review 5.  Psychiatric effects of cannabis use.

Authors:  K Tunving
Journal:  Acta Psychiatr Scand       Date:  1985-09       Impact factor: 6.392

6.  The prevalence of psychiatric disorders in patients with alcohol and other drug problems.

Authors:  H E Ross; F B Glaser; T Germanson
Journal:  Arch Gen Psychiatry       Date:  1988-11

7.  Marijuana sensitivity and panic anxiety.

Authors:  R R Szuster; E B Pontius; P E Campos
Journal:  J Clin Psychiatry       Date:  1988-11       Impact factor: 4.384

8.  Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Wilson M Compton; Bridget F Grant; James D Colliver; Meyer D Glantz; Frederick S Stinson
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

Review 9.  Pharmacotherapeutic considerations in anxiety disorders.

Authors:  L E Hollister
Journal:  J Clin Psychiatry       Date:  1986-06       Impact factor: 4.384

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  27 in total

1.  The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).

Authors:  Julia D Buckner; Richard G Heimberg; Franklin R Schneier; Shang-Min Liu; Shuai Wang; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

Review 2.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

3.  An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy.

Authors:  Matthew T Feldner; Michael J Zvolensky; Kimberly Babson; Ellen W Leen-Feldner; Norman B Schmidt
Journal:  J Anxiety Disord       Date:  2008-01-11

4.  Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users.

Authors:  Michael J Zvolensky; Erin C Marshall; Kirsten Johnson; Julianna Hogan; Amit Bernstein; Marcel O Bonn-Miller
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

5.  Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.

Authors:  Marcel O Bonn-Miller; Megan L Oser; Meggan M Bucossi; Jodie A Trafton
Journal:  J Behav Med       Date:  2012-10-07

6.  Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence.

Authors:  Kirsten Johnson; Jennifer L Mullin; Erin C Marshall; Marcel O Bonn-Miller; Michael Zvolensky
Journal:  Am J Addict       Date:  2010 May-Jun

7.  Immediate antecedents of marijuana use: an analysis from ecological momentary assessment.

Authors:  Julia D Buckner; Ross D Crosby; Jose Silgado; Stephen A Wonderlich; Norman B Schmidt
Journal:  J Behav Ther Exp Psychiatry       Date:  2011-09-14

8.  Medical marijuana laws and suicides by gender and age.

Authors:  D Mark Anderson; Daniel I Rees; Joseph J Sabia
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

9.  Anxious arousal and anhedonic depression symptoms and the frequency of current marijuana use: testing the mediating role of marijuana-use coping motives among active users.

Authors:  Kirsten A Johnson; Marcel O Bonn-Miller; Teresa M Leyro; Michael J Zvolensky
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

10.  The interactive effect of anxiety sensitivity and frequency of marijuana use in terms of anxious responding to bodily sensations among youth.

Authors:  Julia D Buckner; Ellen W Leen-Feldner; Michael J Zvolensky; Norman B Schmidt
Journal:  Psychiatry Res       Date:  2009-03-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.